A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

Clinical trial NCT01958827 · COMPLETED

Trial details

NCT number: NCT01958827
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2013-09-01
Primary completion: 2015-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.